SCHEMBL31606513

SCHEMBL31606513

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(N)=O

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KISS1R Q969F8 5/20 0.54
▸ AGTR1 P30556 1/20 0.53
▸ AGTR2 P50052 1/20 0.53
▸ CXCL8 P10145 8/20 0.51
▸ CASP1 P29466 1/20 0.51
▸ CASP3 P42574 1/20 0.51
▸ CASP4 P49662 1/20 0.51
▸ CASP5 P51878 1/20 0.51
▸ CASP7 P55210 1/20 0.51
▸ CASP9 P55211 1/20 0.51
▸ CASP6 P55212 1/20 0.51
▸ CASP8 Q14790 1/20 0.51
▸ CASP10 Q92851 1/20 0.51
▸ NTSR2 O95665 1/20 0.51
▸ NTSR1 P30989 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31606503 0.96 AGTR1 (0.58) KISS1RAGTR1AGTR2CXCL8CASP1
SCHEMBL31606514 0.95 KISS1R (0.55) KISS1RAGTR1AGTR2CXCL8
SCHEMBL31606474 0.93 AGTR1 (0.56) KISS1RAGTR1AGTR2CXCL8CASP1
SCHEMBL31606523 0.91 KISS1R (0.56) KISS1RAGTR1AGTR2CXCL8CASP1
SCHEMBL31606498 0.89 CXCL8 (0.54) KISS1RCXCL8CASP1CASP3CASP4
SCHEMBL31606485 0.89 CXCL8 (0.56) KISS1RCXCL8
SCHEMBL31606478 0.88 KISS1R (0.56) KISS1RCXCL8CASP1CASP3CASP4
SCHEMBL31606483 0.87 CXCL8 (0.56) KISS1RAGTR1AGTR2CXCL8
SCHEMBL31606507 0.86 CASP1 (0.54) KISS1RCXCL8CASP1CASP3CASP4
SCHEMBL31606497 0.84 CASP1 (0.53) KISS1RCXCL8CASP1CASP3CASP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025109003-A1 P-CADHERIN LIGANDS 3B PHARMACEUTICALS GMBH (DE) 2025-05-30 — — WO disclosed
Send feedback